Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

http://www.wikidata.org/entity/Q34629205

about

Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy Co-infections and Pathogenesis of KSHV-Associated Malignancies Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens KSHV: pathways to tumorigenesis and persistent infection Immunoregulation in Fungal Diseases Pathology in euthermic bats with white nose syndrome suggests a natural manifestation of immune reconstitution inflammatory syndrome Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Treatment of cryptococcosis in the setting of HIV coinfection.Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.Risk factors for mortality from primary cryptococcosis in patients with HIV.Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Progressive multifocal leukoencephalopathy in HIV-1 infection.Unmasking of PML by HAART: unusual clinical features and the role of IRIS Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.Development of fatal acute liver failure in HIV-HBV coinfected patients.Evaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases.Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART.Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia.Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions Noninfectious pulmonary complications of human immunodeficiency virus infection Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Central nervous system disorders after starting antiretroviral therapy in South Africa.Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.Changing patterns in the neuropathogenesis of HIV during the HAART era.Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.Immune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case report Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.

P2860

Q24815428-97662D53-BA61-4E19-BA51-A79AD231DA3A Q26766493-EC6EABB0-F4ED-4B5A-A92D-811182231954 Q26781389-E91ACFD5-44A0-4EAF-861D-A811E16687DD Q27011721-9F103A83-1A60-46CD-BAD2-B811E4572850 Q27026000-4A67E64B-DDCC-4CB1-B983-1ABE4D84B84D Q28074776-2A579131-F2A5-4BB7-A0D1-593BCBA5F90C Q28279296-E7918E34-2E8F-4094-AF1B-DBBD534CB4D0 Q28749315-CFFEC3B0-4323-4C43-8A2B-730FBA12717D Q30252460-F0C7C36E-356B-471E-BE06-5A95113E82D6 Q30366117-5FCB76BD-F96B-45F7-A2D2-70A32384195A Q31034415-EB4876F9-AE34-41ED-985E-BFC5C1415427 Q33157255-7EBA1FC8-E75E-4DCB-8B3E-0F34363CCDE8 Q33442216-27AB0A47-C9E5-4A76-88B8-A822181781CA Q33506561-14A254BF-CE4D-4CF5-90E4-5EE24348F9C7 Q33672408-D12FE85F-4399-4BD4-8647-6A5FB7063E7F Q33823233-1F05E1AE-1B94-4DA7-9775-0AEDC3FBB5FD Q33840983-598450BB-DB96-411C-9E34-9B09B92F16D8 Q34084999-07DFA494-EB2E-4A59-B73E-E6E1233666F6 Q34113607-8F120FFB-2730-4BF4-8157-132B25ACF623 Q34145129-76480E41-6C48-4D69-A4B8-0299EAF965EF Q34251655-ADB6981F-7814-4152-982F-6C064D220873 Q34395892-18460BBB-B594-4B9A-9C4B-6C4429364C4B Q34415055-73E3A8A3-8D20-4DA7-93F3-2AAD9AA51D4A Q34498993-393CF307-CADC-4FE0-9575-27BD7B471947 Q34499007-432DB294-85B6-455F-A0DA-9DA84BC13B08 Q34516548-90748EEE-A2ED-4232-BDA3-3DD705646172 Q34564288-3F09307C-E3DF-47AC-94BA-0441C36ADBD0 Q34587349-0D9C41C6-C851-4D5F-883A-8A8121185136 Q34799534-B7986CCF-9477-4732-B0EB-41D40198DC93 Q35095045-15A6C5A5-F0A7-4538-BF94-B1AB97DE29AB Q35126422-1A752031-6656-43D8-AE05-881832B80497 Q35387470-C6C1795E-4283-46B8-8F72-A887F52C8074 Q35553902-5C894A78-5793-46A6-9EB4-8A74BD9C7C0D Q35715660-4055DE5F-AB31-47C2-8C48-78D1A31D46C6 Q35799766-BA3CC5D1-BFF5-4578-8A38-C3F9AD99CD2D Q35901107-2544F1A1-3147-4214-8CF0-977BEF40A43E Q35901117-B7356DDE-1106-4DB1-87A0-DC61BFF605DA Q35901121-B473A55A-4369-4BA4-BD5B-A6E5C5ED801B Q36088274-7E95D55F-98E1-4786-9B3C-C3A4138794F7 Q36235489-2FB67D38-8B66-4D51-A9A0-2D43EC397967

P2860

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

http://www.wikidata.org/entity/Q34629205

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Immune reconstitution inflamma ...... active antiretroviral therapy.

@ast

Immune reconstitution inflamma ...... active antiretroviral therapy.

@en

Immune reconstitution inflamma ...... active antiretroviral therapy.

@nl

type

label

Immune reconstitution inflamma ...... active antiretroviral therapy.

@ast

Immune reconstitution inflamma ...... active antiretroviral therapy.

@en

Immune reconstitution inflamma ...... active antiretroviral therapy.

@nl

prefLabel

Immune reconstitution inflamma ...... active antiretroviral therapy.

@ast

Immune reconstitution inflamma ...... active antiretroviral therapy.

@en

Immune reconstitution inflamma ...... active antiretroviral therapy.

@nl

P1433

Q34629205-2672FF04-C023-428F-91CE-3DE2845850E6

P1476

Q34629205-BCCD2AD4-7498-4755-96E4-04E65202FA77

P2093

Q34629205-20AD9C6D-FFB1-4B6B-8729-A7516100A243

Q34629205-29844ED5-6762-470B-834C-77659EC04423

Q34629205-39ED120B-4122-4308-B0C6-00D7EF0F3350

Q34629205-7DC22C28-5AF0-43A4-B62B-288549D55B0F

Q34629205-9B75960F-B28D-4455-BD55-1D01A50DAA3E

Q34629205-A012E2E3-1FC2-4246-A6E3-2640C86FA20A

Q34629205-C0321F37-D07E-4CA4-9876-5215BA948ED6

Q34629205-E9B7871B-B56C-445D-B0CF-8E2B8376FA38

P304

Q34629205-D79D95E9-3659-47A2-BC8A-A01C3527C46B

P31

Q34629205-AB8C4675-AA3B-4030-B34F-A5C08EFB9919

P356

Q34629205-D8D4DFAB-E6D6-4D67-91FC-62DDF82E0E5D

P407

Q34629205-A2E5FD94-6058-4BA7-9F90-E9F5402FF39E

P433

Q34629205-8DA5B620-69CA-4362-BEED-1317A36AC808

P478

Q34629205-BC1C9366-8155-460B-A68C-FB966E4FEBF2

P50

Q34629205-E1F33E94-D76D-46BD-A8DC-DF8FE6C23F8D

P577

Q34629205-139EE9A7-E614-476F-BC83-C6FBECC49724

P698

Q34629205-D288AB3D-0C0A-401B-AF1D-2C81AADD5D68

P921

Q34629205-300F81E7-0FD3-4823-9733-912A54B9DD90

Q34629205-86B79C7D-A995-4054-830D-24C91E1F8FC1

P356

00005792-200205000-00005

P1433

P1476

Immune reconstitution inflamma ...... active antiretroviral therapy.

@en

P2093

Barbara W Trautner

http://www.w3.org/2001/XMLSchema#string

Daniel W Musher

http://www.w3.org/2001/XMLSchema#string

Fehmida Visnegarwala

http://www.w3.org/2001/XMLSchema#string

Joseph C Gathe

http://www.w3.org/2001/XMLSchema#string

Maria C Rodriguez-Barradas

http://www.w3.org/2001/XMLSchema#string

Richard J Hamill

http://www.w3.org/2001/XMLSchema#string

Samuel A Shelburne

http://www.w3.org/2001/XMLSchema#string

Stephen B Greenberg

http://www.w3.org/2001/XMLSchema#string

P304

213-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00005792-200205000-00005

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11997718

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug